Medicine & Life Sciences
African Trypanosomiasis
5%
Agglutination Tests
5%
Allopurinol
8%
Animals
8%
Antibodies
7%
Antibody Formation
6%
Babesiosis
5%
Bone Marrow
7%
Canidae
61%
Cattle
6%
Cellular Immunity
10%
Cutaneous Leishmaniasis
13%
Cytokines
11%
Dogs
44%
Extracellular Vesicles
7%
falcipain
6%
Immunomodulation
7%
In Vitro Techniques
6%
Infections
23%
Innate Immunity
8%
Interleukin-10
7%
Interleukin-12
8%
Interleukin-4
5%
Kupffer Cells
8%
Leishmania
46%
Leishmania guyanensis
5%
Leishmania infantum
100%
Leishmaniasis
81%
Liposomes
6%
Liver
11%
Lymph Nodes
8%
Macrophages
11%
Meglumine Antimoniate
16%
miltefosine
5%
Neutrophils
11%
Parasites
58%
Parasitic Diseases
12%
Plasmodium chabaudi
9%
Portugal
21%
Psychodidae
5%
Skin
8%
Spleen
6%
T-Lymphocyte Subsets
5%
T-Lymphocytes
13%
Theileria annulata
12%
Trifluralin
12%
ursolic acid
9%
Vaccines
6%
Visceral Leishmaniasis
38%
Zoonoses
14%
Agriculture & Biology
African trypanosomiasis
5%
allopurinol
14%
amastigotes
21%
animals
5%
antibodies
9%
antibody formation
5%
blood
7%
bone marrow
9%
cell-mediated immunity
5%
cells
6%
cutaneous leishmaniasis
5%
cytokines
14%
dogs
53%
drug therapy
6%
hepatocytes
6%
humoral immunity
6%
immune response
16%
immune system
6%
immunomodulation
8%
immunophenotyping
5%
infection
23%
innate immunity
8%
interleukin-10
8%
interleukin-12
8%
interleukin-4
7%
Kupffer cells
11%
Leishmania
30%
Leishmania donovani
8%
Leishmania guyanensis
5%
Leishmania infantum
75%
Leishmania shawi
6%
leishmaniasis
69%
lymph nodes
10%
macrophages
11%
mice
7%
neutrophils
11%
parasites
37%
pathogenicity
6%
Plasmodium chabaudi
5%
Plasmodium chabaudi chabaudi
6%
Portugal
18%
promastigotes
26%
relapse
7%
skin (animal)
5%
T-lymphocytes
16%
Theileria annulata
10%
therapeutics
8%
trifluralin
5%
ursolic acid
8%
visceral leishmaniasis
23%